持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/12 | 4,050 | 4,170 | 4,035 | 4,135 | +100 | +2.5% | 44,500 |
2020/08/11 | 3,830 | 4,050 | 3,830 | 4,035 | +235 | +6.2% | 60,900 |
2020/08/07 | 3,900 | 3,910 | 3,790 | 3,800 | -85 | -2.2% | 38,000 |
2020/08/06 | 3,930 | 3,930 | 3,875 | 3,885 | -85 | -2.1% | 29,200 |
2020/08/05 | 3,920 | 3,990 | 3,880 | 3,970 | +5 | +0.1% | 29,400 |
2020/08/04 | 3,945 | 4,045 | 3,945 | 3,965 | +35 | +0.9% | 47,700 |
2020/08/03 | 3,910 | 3,960 | 3,830 | 3,930 | +60 | +1.6% | 56,200 |
2020/07/31 | 3,850 | 3,935 | 3,765 | 3,870 | -30 | -0.8% | 49,700 |
2020/07/30 | 3,975 | 3,975 | 3,885 | 3,900 | -60 | -1.5% | 22,300 |
2020/07/29 | 3,945 | 4,020 | 3,905 | 3,960 | +35 | +0.9% | 32,100 |
2020/07/28 | 3,955 | 3,965 | 3,915 | 3,925 | -40 | -1% | 15,700 |
2020/07/27 | 3,905 | 3,980 | 3,880 | 3,965 | +25 | +0.6% | 33,000 |
2020/07/22 | 3,985 | 4,010 | 3,940 | 3,940 | -45 | -1.1% | 27,100 |
2020/07/21 | 3,890 | 3,995 | 3,890 | 3,985 | +70 | +1.8% | 36,100 |
2020/07/20 | 3,895 | 3,920 | 3,835 | 3,915 | +70 | +1.8% | 27,300 |
2020/07/17 | 3,925 | 3,925 | 3,845 | 3,845 | -65 | -1.7% | 26,900 |
2020/07/16 | 3,960 | 3,985 | 3,910 | 3,910 | -60 | -1.5% | 18,200 |
2020/07/15 | 3,920 | 3,985 | 3,920 | 3,970 | +50 | +1.3% | 31,600 |
2020/07/14 | 3,975 | 3,975 | 3,910 | 3,920 | -90 | -2.2% | 42,800 |
2020/07/13 | 3,885 | 4,010 | 3,865 | 4,010 | +195 | +5.1% | 42,400 |
2020/07/10 | 3,870 | 3,875 | 3,815 | 3,815 | -55 | -1.4% | 36,000 |
2020/07/09 | 3,880 | 3,895 | 3,810 | 3,870 | -35 | -0.9% | 36,100 |
2020/07/08 | 3,965 | 4,015 | 3,900 | 3,905 | -70 | -1.8% | 44,000 |
2020/07/07 | 4,030 | 4,030 | 3,950 | 3,975 | -75 | -1.9% | 31,500 |
2020/07/06 | 4,035 | 4,065 | 4,025 | 4,050 | +55 | +1.4% | 26,100 |
2020/07/03 | 3,935 | 4,000 | 3,920 | 3,995 | +60 | +1.5% | 22,900 |
2020/07/02 | 3,965 | 4,010 | 3,935 | 3,935 | +10 | +0.3% | 36,900 |
2020/07/01 | 4,050 | 4,050 | 3,925 | 3,925 | -85 | -2.1% | 35,200 |
2020/06/30 | 4,060 | 4,060 | 4,010 | 4,010 | -50 | -1.2% | 31,600 |
2020/06/29 | 4,075 | 4,085 | 4,010 | 4,060 | -25 | -0.6% | 38,400 |
2020/06/26 | 4,085 | 4,120 | 4,070 | 4,085 | +45 | +1.1% | 39,500 |
2020/06/25 | 4,030 | 4,080 | 4,015 | 4,040 | -25 | -0.6% | 37,200 |
2020/06/24 | 4,145 | 4,145 | 4,065 | 4,065 | -95 | -2.3% | 26,500 |
2020/06/23 | 4,160 | 4,190 | 4,090 | 4,160 | +20 | +0.5% | 25,900 |
2020/06/22 | 4,170 | 4,190 | 4,135 | 4,140 | -30 | -0.7% | 33,600 |
2020/06/19 | 4,155 | 4,190 | 4,060 | 4,170 | +45 | +1.1% | 72,400 |
2020/06/18 | 4,140 | 4,150 | 4,100 | 4,125 | -10 | -0.2% | 25,800 |
2020/06/17 | 4,090 | 4,190 | 4,085 | 4,135 | +55 | +1.3% | 38,200 |
2020/06/16 | 4,030 | 4,090 | 3,970 | 4,080 | +165 | +4.2% | 42,400 |
2020/06/15 | 3,960 | 4,000 | 3,915 | 3,915 | -60 | -1.5% | 22,800 |
2020/06/12 | 3,985 | 4,015 | 3,920 | 3,975 | -80 | -2% | 60,000 |
2020/06/11 | 4,120 | 4,150 | 4,035 | 4,055 | -115 | -2.8% | 35,900 |
2020/06/10 | 4,115 | 4,190 | 4,115 | 4,170 | +65 | +1.6% | 40,900 |
2020/06/09 | 4,135 | 4,150 | 4,095 | 4,105 | +10 | +0.2% | 28,500 |
2020/06/08 | 4,130 | 4,130 | 4,070 | 4,095 | -25 | -0.6% | 33,500 |
2020/06/05 | 4,160 | 4,160 | 4,080 | 4,120 | -55 | -1.3% | 33,800 |
2020/06/04 | 4,200 | 4,210 | 4,105 | 4,175 | -5 | -0.1% | 31,600 |
2020/06/03 | 4,240 | 4,240 | 4,165 | 4,180 | -45 | -1.1% | 29,000 |
2020/06/02 | 4,110 | 4,235 | 4,075 | 4,225 | +150 | +3.7% | 54,800 |
2020/06/01 | 4,205 | 4,220 | 4,065 | 4,075 | -100 | -2.4% | 35,300 |
1051~
1100
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム